Pediculicide [EPC]

Pediculicide [EPC] was reported 4708 times

Drugs of the Pediculicide [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MAZZOTTI REACTION 9 0.8182
1 VISCERAL LARVA MIGRANS 7 0.7778
2 NEMATODIASIS 9 0.2647
3 GASPING SYNDROME 5 0.2381
4 FILARIASIS 9 0.1765
5 HOOKWORM INFECTION 5 0.1471
6 EXPRESSIVE LANGUAGE DISORDER 35 0.1228
7 LICE INFESTATION 25 0.1190
8 DISSEMINATED STRONGYLOIDIASIS 24 0.1096
9 CONGENITAL MUSCLE ABSENCE 4 0.1026
10 SOMATIC DELUSION 21 0.0854
11 MALARIA 59 0.0837
12 STRONGYLOIDIASIS 125 0.0773
13 DRUG DEPENDENCE, ANTEPARTUM 4 0.0769
14 BLOOD SMEAR TEST ABNORMAL 6 0.0750
15 RHINOCEREBRAL MUCORMYCOSIS 26 0.0749
16 SCHISTOSOMIASIS 5 0.0649
17 CONJUNCTIVAL HAEMORRHAGE 237 0.0620
18 SCABIES 6 0.0351
19 ROSACEA 162 0.0347
20 ACARODERMATITIS 32 0.0293
21 INFESTATION 7 0.0270
22 TONGUE HAEMATOMA 5 0.0253
23 HELMINTHIC INFECTION 6 0.0247
24 INFECTION PARASITIC 18 0.0230
25 NUCHAL RIGIDITY 18 0.0199
26 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0189
27 HERPES SIMPLEX HEPATITIS 4 0.0167
28 CEREBELLAR STROKE 5 0.0128
29 ENDOCRINE OPHTHALMOPATHY 11 0.0127
30 GLASGOW COMA SCALE ABNORMAL 4 0.0109
31 METHAEMOGLOBINAEMIA 25 0.0108
32 LOGORRHOEA 38 0.0108
33 KLEBSIELLA TEST POSITIVE 7 0.0108
34 SINUSITIS FUNGAL 8 0.0100
35 ANAL SPHINCTER ATONY 4 0.0093
36 MIXED LIVER INJURY 28 0.0093
37 HYPEREOSINOPHILIC SYNDROME 5 0.0092
38 INTENTION TREMOR 5 0.0088
39 SELF-MEDICATION 34 0.0083
40 SUPRAPUBIC PAIN 4 0.0079
41 LYMPHANGITIS 6 0.0075
42 PUSTULE 17 0.0072
43 PERIARTHRITIS 16 0.0070
44 FAECAL INCONTINENCE 33 0.0069
45 STUPOR 22 0.0068
46 SPIROMETRY ABNORMAL 4 0.0067
47 HEPATORENAL FAILURE 4 0.0066
48 NEUROPSYCHOLOGICAL SYMPTOMS 4 0.0066
49 CORTISOL INCREASED 4 0.0064
50 PERIORAL DERMATITIS 4 0.0063
51 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 5 0.0061
52 ENCEPHALOPATHY 147 0.0060
53 SUPERFICIAL VEIN THROMBOSIS 5 0.0059
54 CHORIORETINOPATHY 8 0.0056
55 OCULAR HYPERAEMIA 265 0.0056
56 BRONCHIAL WALL THICKENING 4 0.0056
57 MONOPARESIS 10 0.0055
58 OSMOTIC DEMYELINATION SYNDROME 4 0.0054
59 SCROTAL SWELLING 5 0.0053
60 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 33 0.0053
61 COMA 248 0.0052
62 GLOMERULONEPHRITIS MEMBRANOUS 6 0.0051
63 FUNGAEMIA 8 0.0051
64 SUPERINFECTION BACTERIAL 4 0.0050
65 VASCULAR PURPURA 7 0.0050
66 PARESIS 11 0.0049
67 MUTISM 7 0.0048
68 CONGENITAL CARDIOVASCULAR ANOMALY 4 0.0048
69 HEPATIC CYTOLYSIS 60 0.0047
70 URINARY INCONTINENCE 138 0.0047
71 CENTRAL NERVOUS SYSTEM INFECTION 5 0.0044
72 APPLICATION SITE INFLAMMATION 6 0.0043
73 CONJUNCTIVAL HYPERAEMIA 15 0.0042
74 GASTROINTESTINAL MOTILITY DISORDER 22 0.0041
75 PSEUDOMONAL SEPSIS 7 0.0040
76 TOXIC ENCEPHALOPATHY 20 0.0039
77 VERTIGO 219 0.0036
78 RHEUMATOID FACTOR INCREASED 4 0.0036
79 PRURITUS ALLERGIC 4 0.0034
80 URINE ODOUR ABNORMAL 20 0.0034
81 PARAPARESIS 6 0.0034
82 SUPERINFECTION 5 0.0033
83 PULSE ABNORMAL 8 0.0033
84 PNEUMONIA KLEBSIELLA 6 0.0033
85 INTRA-ABDOMINAL HAEMATOMA 4 0.0032
86 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 24 0.0032
87 ANOREXIA 41 0.0032
88 DANDRUFF 7 0.0032
89 DERMATITIS CONTACT 36 0.0032
90 DEPRESSED LEVEL OF CONSCIOUSNESS 124 0.0031
91 LICHENOID KERATOSIS 7 0.0031
92 HYPERSENSITIVITY VASCULITIS 8 0.0030
93 GASTRITIS EROSIVE 14 0.0030
94 ESCHERICHIA BACTERAEMIA 7 0.0030
95 DECUBITUS ULCER 24 0.0029
96 ABNORMAL FAECES 24 0.0029
97 EOSINOPHILIA 51 0.0029
98 DIABETES INSIPIDUS 7 0.0029
99 APLASIA PURE RED CELL 10 0.0029
100 SKIN HYPOPIGMENTATION 5 0.0028
101 RASH PAPULAR 63 0.0028
102 PRODUCT PRESCRIBING ISSUE 61 0.0028
103 COMA SCALE ABNORMAL 8 0.0028
104 BODY TEMPERATURE ABNORMAL 5 0.0027
105 MARASMUS 4 0.0026
106 DIFFICULTY IN WALKING 9 0.0026
107 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
108 HYPERAMMONAEMIA 13 0.0026
109 SKIN DISCOMFORT 7 0.0026
110 FORMICATION 18 0.0026
111 NEUROTOXICITY 45 0.0026
112 UNDERWEIGHT 5 0.0025
113 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
114 EYELID OEDEMA 29 0.0025
115 HEPATOCELLULAR INJURY 35 0.0025
116 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 5 0.0024
117 BRONCHOPULMONARY ASPERGILLOSIS 19 0.0024
118 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
119 CYTOLYTIC HEPATITIS 8 0.0024
120 CHEILITIS 13 0.0024
121 DERMATITIS ALLERGIC 30 0.0024
122 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
123 SKIN WOUND 4 0.0024
124 MUCORMYCOSIS 6 0.0023
125 MULTIPLE ORGAN DYSFUNCTION SYNDROME 65 0.0023
126 CERVICAL DYSPLASIA 5 0.0023
127 ENTEROCOCCAL INFECTION 11 0.0023
128 BRAIN DEATH 7 0.0023
129 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
130 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 66 0.0023
131 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0022
132 BLOOD PHOSPHORUS DECREASED 8 0.0022
133 PAIN OF SKIN 57 0.0021
134 URINARY HESITATION 5 0.0021
135 BLOOD IMMUNOGLOBULIN E INCREASED 5 0.0021
136 APPLICATION SITE DRYNESS 7 0.0021
137 FAECES HARD 8 0.0021
138 CARBOHYDRATE ANTIGEN 125 INCREASED 7 0.0021
139 DERMATITIS 42 0.0020
140 TACHYARRHYTHMIA 5 0.0020
141 HYPERPARATHYROIDISM SECONDARY 5 0.0020
142 PRODUCT USE IN UNAPPROVED INDICATION 490 0.0020
143 LOCALISED OEDEMA 9 0.0019
144 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 50 0.0019
145 ABNORMAL BEHAVIOUR 76 0.0019
146 LIVEDO RETICULARIS 4 0.0019
147 SKIN TIGHTNESS 9 0.0019
148 SEBORRHOEA 7 0.0019
149 RALES 11 0.0019
150 SKIN IRRITATION 86 0.0019
151 TEMPOROMANDIBULAR JOINT SYNDROME 5 0.0019
152 PEMPHIGOID 14 0.0019
153 APHASIA 56 0.0019
154 SHOCK HAEMORRHAGIC 15 0.0018
155 BACTERIAL SEPSIS 6 0.0018
156 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 101 0.0018
157 CEREBELLAR SYNDROME 4 0.0018
158 DEAFNESS NEUROSENSORY 6 0.0018
159 RED BLOOD CELL COUNT INCREASED 5 0.0018
160 PRODUCT PHYSICAL CONSISTENCY ISSUE 10 0.0018
161 HYPERNATRAEMIA 9 0.0018
162 APPLICATION SITE SWELLING 9 0.0018
163 LYME DISEASE 6 0.0018
164 DERMATITIS BULLOUS 13 0.0018
165 RASH PUSTULAR 13 0.0018
166 MULTIPLE USE OF SINGLE-USE PRODUCT 10 0.0018
167 KLEBSIELLA INFECTION 9 0.0018
168 INTENTIONAL UNDERDOSE 13 0.0018
169 SKIN BURNING SENSATION 125 0.0017
170 HYPERREFLEXIA 6 0.0017
171 SKIN WARM 10 0.0017
172 APPLICATION SITE EXFOLIATION 7 0.0017
173 CREPITATIONS 5 0.0017
174 PERIPHERAL COLDNESS 23 0.0017
175 ORAL DISCOMFORT 23 0.0017
176 REBOUND ACID HYPERSECRETION 5 0.0017
177 VENTRICULAR ARRHYTHMIA 6 0.0016
178 RASH MACULO-PAPULAR 36 0.0016
179 INTRACRANIAL PRESSURE INCREASED 9 0.0016
180 ASTHENIA 606 0.0016
181 DERMATITIS EXFOLIATIVE 8 0.0016
182 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
183 ESCHERICHIA INFECTION 13 0.0016
184 EOSINOPHIL COUNT INCREASED 13 0.0016
185 ORAL INFECTION 6 0.0015
186 STEVENS-JOHNSON SYNDROME 34 0.0015
187 COVID-19 PNEUMONIA 18 0.0015
188 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
189 LUNG OPACITY 4 0.0015
190 POLYARTHRITIS 8 0.0015
191 PYREXIA 516 0.0015
192 SCAB 17 0.0015
193 CANDIDA INFECTION 25 0.0015
194 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
195 SEPTIC SHOCK 62 0.0014
196 POOR QUALITY PRODUCT ADMINISTERED 15 0.0014
197 APPLICATION SITE BURN 7 0.0014
198 MUSCLE FATIGUE 6 0.0014
199 PERIORBITAL SWELLING 8 0.0014
200 SKIN HYPERPIGMENTATION 12 0.0014
201 IMPAIRED QUALITY OF LIFE 20 0.0014
202 INCOHERENT 9 0.0014
203 EYELID MARGIN CRUSTING 4 0.0014
204 SKIN SWELLING 12 0.0014
205 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
206 ESCHERICHIA SEPSIS 4 0.0014
207 ELECTROLYTE IMBALANCE 16 0.0014
208 ONYCHOMYCOSIS 6 0.0014
209 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
210 PERIORBITAL OEDEMA 7 0.0013
211 MENINGITIS 9 0.0013
212 PRODUCT ODOUR ABNORMAL 14 0.0013
213 MUSCULOSKELETAL DISCOMFORT 23 0.0013
214 METABOLIC ENCEPHALOPATHY 4 0.0013
215 ACNE CYSTIC 4 0.0013
216 INCONTINENCE 14 0.0013
217 HEMIPLEGIA 11 0.0013
218 NYSTAGMUS 7 0.0013
219 DUODENITIS 4 0.0013
220 ENCEPHALITIS 9 0.0013
221 DRUG ADMINISTRATION ERROR 39 0.0013
222 DYSSTASIA 37 0.0013
223 POISONING DELIBERATE 12 0.0013
224 TESTICULAR PAIN 4 0.0013
225 SUBSTANCE USE DISORDER 4 0.0013
226 NERVOUS SYSTEM DISORDER 39 0.0012
227 DISORIENTATION 49 0.0012
228 HERPES SIMPLEX 8 0.0012
229 MENTAL STATUS CHANGES 34 0.0012
230 ERYTHEMA 251 0.0012
231 HYPERCALCAEMIA 15 0.0012
232 BLOOD PRESSURE ABNORMAL 24 0.0012
233 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 6 0.0012
234 AGRANULOCYTOSIS 22 0.0012
235 BACTERAEMIA 14 0.0012
236 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 6 0.0012
237 ABNORMAL SENSATION IN EYE 5 0.0012
238 CHROMATURIA 26 0.0012
239 PETECHIAE 12 0.0011
240 ACUTE RESPIRATORY FAILURE 22 0.0011
241 BRONCHIOLITIS 4 0.0011
242 PAPULE 8 0.0011
243 GENERALISED OEDEMA 14 0.0011
244 PHYSICAL DISABILITY 5 0.0011
245 FIBRIN D DIMER INCREASED 4 0.0011
246 SKIN WEEPING 4 0.0011
247 PHOTOPSIA 7 0.0011
248 PRURITUS 423 0.0011
249 ATAXIA 13 0.0011
250 HEADACHE 685 0.0011
251 HAIR DISORDER 9 0.0011
252 FOOD INTOLERANCE 4 0.0011
253 AGITATION 80 0.0011
254 PARADOXICAL DRUG REACTION 4 0.0011
255 VIRAL MUTATION IDENTIFIED 4 0.0011
256 ARTHROPOD BITE 8 0.0011
257 HEART RATE ABNORMAL 6 0.0011
258 SKIN REACTION 15 0.0011
259 HEPATIC NECROSIS 4 0.0011
260 SWELLING FACE 69 0.0011
261 PARANASAL SINUS DISCOMFORT 4 0.0011
262 ILEUS 13 0.0010
263 APPLICATION SITE PAIN 23 0.0010
264 BLOOD MAGNESIUM DECREASED 9 0.0010
265 SECRETION DISCHARGE 13 0.0010
266 BACK PAIN 241 0.0010
267 VASCULITIS 12 0.0010
268 HEPATOMEGALY 10 0.0010
269 PURPURA 9 0.0010
270 HEPATITIS 26 0.0010
271 FACE OEDEMA 17 0.0010
272 AUTOIMMUNE HEPATITIS 7 0.0010
273 DEFAECATION URGENCY 7 0.0010
274 DUODENAL ULCER 7 0.0010
275 APPLICATION SITE ERYTHEMA 26 0.0010
276 CHOLESTASIS 19 0.0010
277 VITAMIN B12 DEFICIENCY 4 0.0010
278 DERMATITIS ACNEIFORM 6 0.0010
279 APPLICATION SITE DISCOLOURATION 4 0.0010
280 SKIN EXFOLIATION 83 0.0010
281 RASH ERYTHEMATOUS 47 0.0010
282 PERIPHERAL VENOUS DISEASE 4 0.0010
283 EAR INFECTION 26 0.0010
284 INTENTIONAL PRODUCT MISUSE 85 0.0010
285 CONJUNCTIVITIS 18 0.0010
286 OLIGURIA 6 0.0010
287 ERYTHEMA MULTIFORME 9 0.0010
288 THYROID FUNCTION TEST ABNORMAL 4 0.0010
289 EYE DISCHARGE 10 0.0010
290 SWOLLEN TONGUE 30 0.0010
291 APLASTIC ANAEMIA 5 0.0010
292 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
293 SWELLING OF EYELID 6 0.0010
294 INFUSION SITE SWELLING 6 0.0010
295 INFUSION SITE ERYTHEMA 8 0.0009
296 CHILLS 111 0.0009
297 CEREBRAL DISORDER 7 0.0009
298 HEPATIC PAIN 4 0.0009
299 SPEECH DISORDER 49 0.0009
300 VIROLOGIC FAILURE 5 0.0009
301 SKIN DISORDER 31 0.0009
302 MULTI-ORGAN FAILURE 16 0.0009
303 CARDIAC MURMUR 8 0.0009
304 HORDEOLUM 4 0.0009
305 INCORRECT DRUG ADMINISTRATION DURATION 26 0.0009
306 ERYTHEMA OF EYELID 5 0.0009
307 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
308 OCULAR ICTERUS 4 0.0009
309 PRODUCT AVAILABILITY ISSUE 21 0.0009
310 GAIT DISTURBANCE 176 0.0009
311 HYPERTHERMIA 7 0.0009
312 IMMOBILE 4 0.0009
313 ACIDOSIS 7 0.0009
314 RESPIRATORY FAILURE 66 0.0009
315 EXPIRED PRODUCT ADMINISTERED 30 0.0009
316 LIP SWELLING 30 0.0009
317 SKIN MASS 6 0.0009
318 TORSADE DE POINTES 7 0.0009
319 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
320 OCULAR DISCOMFORT 10 0.0009
321 TACHYPNOEA 12 0.0009
322 PRURITUS GENERALISED 19 0.0009
323 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
324 RED BLOOD CELL COUNT DECREASED 25 0.0009
325 HYPERBILIRUBINAEMIA 9 0.0009
326 SYNOVIAL CYST 4 0.0009
327 NEPHROGENIC ANAEMIA 4 0.0009
328 HYPERVENTILATION 5 0.0009
329 NECK PAIN 48 0.0009
330 MYDRIASIS 11 0.0009
331 SCRATCH 9 0.0009
332 SUDDEN DEATH 9 0.0008
333 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
334 METABOLIC ACIDOSIS 27 0.0008
335 HEREDITARY ANGIOEDEMA 9 0.0008
336 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
337 HORMONE LEVEL ABNORMAL 4 0.0008
338 ORAL DISORDER 6 0.0008
339 VITREOUS FLOATERS 8 0.0008
340 SMALL INTESTINAL OBSTRUCTION 10 0.0008
341 HYPOPHOSPHATAEMIA 6 0.0008
342 LOSS OF CONSCIOUSNESS 104 0.0008
343 INTENTIONAL PRODUCT USE ISSUE 71 0.0008
344 ABASIA 20 0.0008
345 MUCOUS STOOLS 4 0.0008
346 INFLAMMATORY MARKER INCREASED 4 0.0008
347 MALNUTRITION 9 0.0008
348 INFUSION SITE EXTRAVASATION 5 0.0008
349 PRE-EXISTING CONDITION IMPROVED 5 0.0008
350 RASH MACULAR 28 0.0008
351 MYALGIA 135 0.0008
352 BRAIN OEDEMA 10 0.0008
353 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
354 INFUSION SITE PAIN 10 0.0008
355 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
356 HEPATITIS ACUTE 5 0.0008
357 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
358 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
359 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
360 PARTIAL SEIZURES 4 0.0008
361 HEPATIC FAILURE 23 0.0008
362 IMMUNE SYSTEM DISORDER 10 0.0008
363 THERAPEUTIC RESPONSE UNEXPECTED 34 0.0008
364 DRY SKIN 101 0.0008
365 APATHY 11 0.0008
366 APPLICATION SITE PRURITUS 17 0.0007
367 URINARY RETENTION 25 0.0007
368 BLOOD DISORDER 6 0.0007
369 ASCITES 22 0.0007
370 SKIN HAEMORRHAGE 11 0.0007
371 HYPOXIA 26 0.0007
372 RASH PRURITIC 40 0.0007
373 HEAD DISCOMFORT 13 0.0007
374 HYDROCEPHALUS 4 0.0007
375 DRUG ERUPTION 13 0.0007
376 HICCUPS 6 0.0007
377 SKIN LESION 20 0.0007
378 ADVERSE EVENT 67 0.0007
379 ONYCHOCLASIS 5 0.0007
380 EYE SWELLING 27 0.0007
381 APPLICATION SITE IRRITATION 9 0.0007
382 CYTOMEGALOVIRUS INFECTION 12 0.0007
383 HEPATOTOXICITY 16 0.0007
384 FEELING COLD 20 0.0007
385 VITAMIN D DEFICIENCY 7 0.0007
386 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 51 0.0007
387 EXTRASYSTOLES 5 0.0007
388 MUSCULOSKELETAL CHEST PAIN 11 0.0007
389 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
390 JAUNDICE 19 0.0007
391 ABSCESS LIMB 3 0.0007
392 GENERALISED ERYTHEMA 4 0.0007
393 DRUG-INDUCED LIVER INJURY 22 0.0007
394 NEUROLOGICAL SYMPTOM 4 0.0007
395 PSEUDOMONAS INFECTION 6 0.0007
396 ANURIA 6 0.0007
397 THERAPY NON-RESPONDER 31 0.0007
398 ORTHOSTATIC HYPOTENSION 12 0.0007
399 DRY THROAT 7 0.0007
400 TOOTH ABSCESS 7 0.0007
401 DRUG INTERACTION 109 0.0007
402 NAIL DISORDER 6 0.0007
403 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
404 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
405 SARS-COV-2 TEST POSITIVE 9 0.0007
406 LUNG INFILTRATION 6 0.0007
407 SENSITIVE SKIN 5 0.0007
408 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
409 FEELING DRUNK 5 0.0007
410 FACIAL PAIN 6 0.0007
411 ERUCTATION 13 0.0007
412 COVID-19 117 0.0007
413 HEPATITIS CHOLESTATIC 4 0.0007
414 OSTEOPENIA 10 0.0007
415 DRUG INEFFECTIVE 868 0.0007
416 HYPOTENSION 131 0.0007
417 RESPIRATORY DISTRESS 18 0.0007
418 UROSEPSIS 6 0.0006
419 CONFUSIONAL STATE 105 0.0006
420 FOOD ALLERGY 5 0.0006
421 PRODUCT DISTRIBUTION ISSUE 6 0.0006
422 SCOLIOSIS 4 0.0006
423 DIARRHOEA HAEMORRHAGIC 6 0.0006
424 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
425 BLISTER 36 0.0006
426 PNEUMONIA ASPIRATION 16 0.0006
427 HEART RATE INCREASED 63 0.0006
428 SEASONAL ALLERGY 9 0.0006
429 PRODUCT USE COMPLAINT 10 0.0006
430 LIVER DISORDER 28 0.0006
431 INTENTIONAL DOSE OMISSION 18 0.0006
432 PARALYSIS 9 0.0006
433 SEPSIS 70 0.0006
434 FOREIGN BODY SENSATION IN EYES 4 0.0006
435 ATRIAL FLUTTER 5 0.0006
436 DERMATITIS ATOPIC 33 0.0006
437 ENTERITIS 4 0.0006
438 OFF LABEL USE 545 0.0006
439 PROCTALGIA 4 0.0006
440 ATELECTASIS 6 0.0006
441 EYE PAIN 35 0.0006
442 PRESCRIBED OVERDOSE 12 0.0006
443 UNRESPONSIVE TO STIMULI 16 0.0006
444 DRY MOUTH 50 0.0006
445 PHARYNGEAL SWELLING 6 0.0006
446 EATING DISORDER 13 0.0006
447 ASPERGILLUS INFECTION 4 0.0006
448 EYE IRRITATION 35 0.0006
449 ORAL CANDIDIASIS 8 0.0006
450 SALIVARY HYPERSECRETION 6 0.0006
451 BURNING SENSATION 42 0.0006
452 BRONCHIECTASIS 4 0.0006
453 WRONG PRODUCT ADMINISTERED 4 0.0006
454 DRUG LEVEL DECREASED 6 0.0006
455 INSURANCE ISSUE 9 0.0006
456 SLUGGISHNESS 6 0.0006
457 SKIN DISCOLOURATION 27 0.0006
458 ACUTE HEPATIC FAILURE 8 0.0006
459 PHOTOPHOBIA 11 0.0006
460 SCAR 10 0.0006
461 APPLICATION SITE RASH 8 0.0006
462 TEMPERATURE INTOLERANCE 6 0.0006
463 RESPIRATION ABNORMAL 4 0.0006
464 DELIRIUM 20 0.0006
465 LARGE INTESTINE PERFORATION 4 0.0006
466 BRAIN FOG 9 0.0006
467 CYTOPENIA 7 0.0006
468 APPLICATION SITE REACTION 4 0.0006
469 TUMOUR LYSIS SYNDROME 5 0.0006
470 EYE PRURITUS 19 0.0006
471 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
472 TOXICITY TO VARIOUS AGENTS 95 0.0006
473 WHITE BLOOD CELL COUNT DECREASED 61 0.0006
474 LACRIMATION INCREASED 17 0.0006
475 POISONING 7 0.0006
476 CONDITION AGGRAVATED 169 0.0006
477 ACUTE KIDNEY INJURY 85 0.0006
478 ECZEMA 29 0.0006
479 ACNE 42 0.0006
480 ABDOMINAL PAIN LOWER 14 0.0006
481 OROPHARYNGEAL DISCOMFORT 5 0.0006
482 VISION BLURRED 76 0.0006
483 SKIN LACERATION 6 0.0006
484 ARTHRALGIA 229 0.0006
485 INJECTION SITE IRRITATION 7 0.0005
486 PATHOGEN RESISTANCE 5 0.0005
487 PHOTOSENSITIVITY REACTION 9 0.0005
488 PNEUMONIA BACTERIAL 5 0.0005
489 INCREASED TENDENCY TO BRUISE 5 0.0005
490 BLINDNESS TRANSIENT 4 0.0005
491 OEDEMA PERIPHERAL 66 0.0005
492 BODY TEMPERATURE INCREASED 11 0.0005
493 BLOOD UREA INCREASED 9 0.0005
494 PRODUCT USE ISSUE 101 0.0005
495 PRODUCT PREPARATION ERROR 11 0.0005
496 RESPIRATORY DISORDER 16 0.0005
497 OEDEMA 29 0.0005
498 ANHEDONIA 14 0.0005
499 EYE INFECTION 6 0.0005
500 HOT FLUSH 40 0.0005
501 LUNG DISORDER 26 0.0005
502 HAEMATOCHEZIA 29 0.0005
503 RASH 229 0.0005
504 HAEMODYNAMIC INSTABILITY 4 0.0005
505 INFLAMMATION 27 0.0005
506 JOINT RANGE OF MOTION DECREASED 7 0.0005
507 SHOCK 12 0.0005
508 PHARYNGEAL OEDEMA 8 0.0005
509 TREATMENT FAILURE 43 0.0005
510 BLOOD BILIRUBIN INCREASED 14 0.0005
511 BLINDNESS 21 0.0005
512 APNOEA 4 0.0005
513 ORAL HERPES 10 0.0005
514 MULTIPLE ALLERGIES 4 0.0005
515 FUNGAL INFECTION 17 0.0005
516 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
517 LYMPHADENOPATHY 18 0.0005
518 DIARRHOEA 328 0.0005
519 BODY TEMPERATURE DECREASED 5 0.0005
520 ABDOMINAL PAIN 118 0.0005
521 DRUG RESISTANCE 13 0.0005
522 MENTAL DISORDER 22 0.0005
523 PRODUCT PRESCRIBING ERROR 12 0.0005
524 MYOCLONUS 6 0.0005
525 PRODUCTIVE COUGH 24 0.0005
526 CYSTITIS 16 0.0005
527 SEIZURE 58 0.0005
528 CHRONIC KIDNEY DISEASE 38 0.0005
529 VOMITING 235 0.0005
530 BLOOD POTASSIUM DECREASED 15 0.0005
531 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
532 SENSORY LOSS 4 0.0005
533 NO ADVERSE EVENT 90 0.0005
534 RHINITIS 4 0.0005
535 LYMPHOPENIA 7 0.0005
536 GASTRITIS 13 0.0005
537 DISCOMFORT 30 0.0005
538 FEELING HOT 30 0.0005
539 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
540 EAR DISCOMFORT 5 0.0005
541 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
542 CYST 6 0.0005
543 POOR VENOUS ACCESS 5 0.0005
544 BACTERIAL INFECTION 9 0.0005
545 HEPATIC FUNCTION ABNORMAL 18 0.0005
546 COAGULOPATHY 8 0.0005
547 HYPONATRAEMIA 27 0.0005
548 CARDIO-RESPIRATORY ARREST 20 0.0005
549 DYSARTHRIA 18 0.0005
550 WEIGHT FLUCTUATION 5 0.0005
551 PALLOR 13 0.0005
552 COLITIS 18 0.0005
553 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
554 MYELOSUPPRESSION 17 0.0005
555 RENAL PAIN 5 0.0005
556 CIRCULATORY COLLAPSE 8 0.0005
557 FACIAL PARALYSIS 4 0.0005
558 VITAMIN D DECREASED 4 0.0005
559 SKIN ULCER 12 0.0005
560 DECREASED ACTIVITY 5 0.0005
561 DIPLOPIA 12 0.0005
562 ECONOMIC PROBLEM 7 0.0005
563 NODULE 6 0.0005
564 RENAL FAILURE 61 0.0005
565 WOUND INFECTION 5 0.0005
566 THROMBOCYTOPENIA 51 0.0005
567 PULMONARY CONGESTION 6 0.0005
568 FLUSHING 46 0.0005
569 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
570 BALANCE DISORDER 39 0.0005
571 CYTOKINE RELEASE SYNDROME 9 0.0004
572 URTICARIA 75 0.0004
573 PANCYTOPENIA 25 0.0004
574 GASTROINTESTINAL INFECTION 4 0.0004
575 ANAL INCONTINENCE 4 0.0004
576 REBOUND EFFECT 5 0.0004
577 LEUKOCYTOSIS 8 0.0004
578 ABDOMINAL DISTENSION 46 0.0004
579 ULCER 7 0.0004
580 END STAGE RENAL DISEASE 8 0.0004
581 EXOSTOSIS 4 0.0004
582 CELLULITIS 22 0.0004
583 MYOCARDITIS 5 0.0004
584 TINNITUS 20 0.0004
585 HAEMATEMESIS 11 0.0004
586 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
587 HUNGER 6 0.0004
588 APHONIA 6 0.0004
589 ALOPECIA 84 0.0004
590 MOUTH ULCERATION 9 0.0004
591 ILLNESS 44 0.0004
592 EYE DISORDER 14 0.0004
593 HEPATIC CIRRHOSIS 8 0.0004
594 ABORTION INDUCED 4 0.0004
595 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
596 MUSCULOSKELETAL STIFFNESS 37 0.0004
597 SOMNOLENCE 85 0.0004
598 PARAESTHESIA 66 0.0004
599 JOINT STIFFNESS 11 0.0004
600 LIVER FUNCTION TEST INCREASED 9 0.0004
601 GAIT INABILITY 14 0.0004
602 MACULAR DEGENERATION 5 0.0004
603 TACHYCARDIA 37 0.0004
604 AFFECT LABILITY 4 0.0004
605 FAECES DISCOLOURED 9 0.0004
606 GASTROENTERITIS 6 0.0004
607 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 74 0.0004
608 DYSPHONIA 24 0.0004
609 ACCIDENTAL OVERDOSE 15 0.0004
610 MELAENA 9 0.0004
611 BLOOD PRESSURE DECREASED 27 0.0004
612 INTENTIONAL OVERDOSE 26 0.0004
613 WEIGHT DECREASED 113 0.0004
614 TRANSAMINASES INCREASED 9 0.0004
615 DISABILITY 8 0.0004
616 LIGAMENT SPRAIN 4 0.0004
617 DRY EYE 20 0.0004
618 DYSPHAGIA 38 0.0004
619 DISEASE RECURRENCE 19 0.0004
620 BRAIN INJURY 4 0.0004
621 BLOOD CREATININE INCREASED 26 0.0004
622 DEHYDRATION 53 0.0004
623 TOXIC SKIN ERUPTION 4 0.0004
624 BRADYCARDIA 21 0.0004
625 PRODUCT ADMINISTRATION ERROR 8 0.0004
626 MUSCLE ATROPHY 5 0.0004
627 FEEDING DISORDER 8 0.0004
628 HAEMOPTYSIS 11 0.0004
629 PSORIATIC ARTHROPATHY 16 0.0004
630 STAPHYLOCOCCAL INFECTION 13 0.0004
631 EYELID PTOSIS 4 0.0004
632 HYPERSENSITIVITY 73 0.0004
633 HYPOGLYCAEMIA 19 0.0004
634 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
635 NEUTROPHIL COUNT INCREASED 4 0.0004
636 MUSCLE TWITCHING 9 0.0004
637 OSTEOPOROSIS 16 0.0004
638 ANAPHYLACTIC SHOCK 10 0.0004
639 HIATUS HERNIA 5 0.0004
640 CARDIAC FAILURE 31 0.0004
641 VENTRICULAR EXTRASYSTOLES 4 0.0004
642 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 13 0.0004
643 THERAPY PARTIAL RESPONDER 6 0.0004
644 TENDERNESS 4 0.0004
645 HYPERSOMNIA 11 0.0004
646 FOLLICULITIS 4 0.0004
647 URINARY TRACT INFECTION 65 0.0004
648 TOOTH INFECTION 5 0.0004
649 HALLUCINATION, VISUAL 8 0.0004
650 ADVERSE REACTION 5 0.0004
651 BODY HEIGHT DECREASED 4 0.0004
652 OXYGEN SATURATION DECREASED 21 0.0004
653 BLOOD SODIUM DECREASED 7 0.0004
654 VISUAL IMPAIRMENT 46 0.0004
655 OVERDOSE 80 0.0004
656 HYPOCALCAEMIA 7 0.0004
657 PHARYNGITIS STREPTOCOCCAL 4 0.0004
658 PNEUMONITIS 10 0.0004
659 OESOPHAGITIS 4 0.0004
660 IRRITABILITY 22 0.0004
661 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
662 GASTROINTESTINAL PAIN 4 0.0004
663 ANGIOEDEMA 16 0.0004
664 SINUSITIS 37 0.0004
665 VENTRICULAR FIBRILLATION 4 0.0004
666 EAR PAIN 7 0.0004
667 SKIN FISSURES 7 0.0004
668 BLOOD CALCIUM DECREASED 4 0.0004
669 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
670 STATUS EPILEPTICUS 4 0.0004
671 HAEMATURIA 12 0.0004
672 BRONCHOSPASM 5 0.0004
673 CHOLECYSTECTOMY 4 0.0003
674 PARAESTHESIA ORAL 5 0.0003
675 COUGH 97 0.0003
676 HYPOKINESIA 5 0.0003
677 TREMOR 57 0.0003
678 PAIN 210 0.0003
679 DRUG INTOLERANCE 33 0.0003
680 SPINAL PAIN 4 0.0003
681 LACTIC ACIDOSIS 11 0.0003
682 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
683 MUSCLE RIGIDITY 4 0.0003
684 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
685 INFLUENZA 37 0.0003
686 HALLUCINATION 25 0.0003
687 TOOTHACHE 6 0.0003
688 JOINT SWELLING 40 0.0003
689 LIMB INJURY 9 0.0003
690 VISUAL ACUITY REDUCED 11 0.0003
691 BURSITIS 4 0.0003
692 ADRENAL INSUFFICIENCY 4 0.0003
693 PRESYNCOPE 8 0.0003
694 CEREBRAL INFARCTION 8 0.0003
695 RHINORRHOEA 21 0.0003
696 PERIPHERAL SWELLING 50 0.0003
697 PALPITATIONS 38 0.0003
698 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
699 GASTROOESOPHAGEAL REFLUX DISEASE 26 0.0003
700 TENDONITIS 5 0.0003
701 AMNESIA 21 0.0003
702 PHARYNGITIS 4 0.0003
703 HEPATIC STEATOSIS 6 0.0003
704 EXPOSURE DURING PREGNANCY 20 0.0003
705 ABDOMINAL PAIN UPPER 66 0.0003
706 BASAL CELL CARCINOMA 5 0.0003
707 PLATELET COUNT DECREASED 34 0.0003
708 ASTHMA 36 0.0003
709 INFECTION 46 0.0003
710 PAIN IN JAW 9 0.0003
711 FLATULENCE 18 0.0003
712 MUSCULAR WEAKNESS 36 0.0003
713 FOOT FRACTURE 6 0.0003
714 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
715 RESPIRATORY TRACT CONGESTION 5 0.0003
716 SLEEP APNOEA SYNDROME 6 0.0003
717 HYPERKALAEMIA 11 0.0003
718 THERAPEUTIC RESPONSE DECREASED 19 0.0003
719 OROPHARYNGEAL PAIN 29 0.0003
720 ORAL PAIN 7 0.0003
721 PNEUMONIA 101 0.0003
722 SLEEP DISORDER 22 0.0003
723 PANCREATITIS ACUTE 7 0.0003
724 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
725 MUSCLE TIGHTNESS 5 0.0003
726 ATRIAL FIBRILLATION 30 0.0003
727 DYSPNOEA 174 0.0003
728 RESPIRATORY TRACT INFECTION 8 0.0003
729 RENAL FAILURE ACUTE 13 0.0003
730 KIDNEY INFECTION 6 0.0003
731 DECREASED APPETITE 71 0.0003
732 METASTASES TO BONE 5 0.0003
733 BEDRIDDEN 4 0.0003
734 SINUS DISORDER 6 0.0003
735 CRYING 11 0.0003
736 HAEMATOCRIT DECREASED 6 0.0003
737 GENERAL PHYSICAL HEALTH DETERIORATION 35 0.0003
738 HYPERGLYCAEMIA 11 0.0003
739 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
740 GASTROINTESTINAL DISORDER 27 0.0003
741 SYNCOPE 30 0.0003
742 AGGRESSION 15 0.0003
743 PRODUCT DOSE OMISSION ISSUE 88 0.0003
744 FREQUENT BOWEL MOVEMENTS 8 0.0003
745 SINUS CONGESTION 4 0.0003
746 THROAT TIGHTNESS 8 0.0003
747 ARRHYTHMIA 14 0.0003
748 PRODUCT QUALITY ISSUE 40 0.0003
749 BLOOD PRESSURE INCREASED 45 0.0003
750 HYPOAESTHESIA 44 0.0003
751 GINGIVAL BLEEDING 4 0.0003
752 INSOMNIA 78 0.0003
753 FATIGUE 226 0.0003
754 RESPIRATORY ARREST 8 0.0003
755 ANAEMIA 55 0.0003
756 MASS 4 0.0003
757 CHEST PAIN 53 0.0003
758 BLOOD TEST ABNORMAL 4 0.0003
759 BLINDNESS UNILATERAL 4 0.0003
760 MUSCLE SPASMS 52 0.0003
761 HYPOTHYROIDISM 9 0.0003
762 SINUS TACHYCARDIA 4 0.0003
763 EMOTIONAL DISTRESS 34 0.0003
764 CONVULSION 16 0.0003
765 INCORRECT ROUTE OF DRUG ADMINISTRATION 10 0.0003
766 NEUTROPENIA 38 0.0003
767 NIGHT SWEATS 9 0.0003
768 HEPATIC ENZYME INCREASED 19 0.0003
769 DIZZINESS 139 0.0003
770 LETHARGY 16 0.0003
771 GASTROENTERITIS VIRAL 5 0.0003
772 ANOSMIA 4 0.0003
773 CARDIOVASCULAR DISORDER 7 0.0003
774 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
775 CHOLELITHIASIS 9 0.0003
776 DYSPEPSIA 27 0.0003
777 RENAL IMPAIRMENT 23 0.0003
778 SURGERY 16 0.0003
779 ERECTILE DYSFUNCTION 7 0.0003
780 TOOTH DISORDER 6 0.0003
781 PULMONARY MASS 4 0.0003
782 COLON CANCER 4 0.0003
783 THINKING ABNORMAL 5 0.0003
784 IMMUNODEFICIENCY 4 0.0003
785 MUCOSAL INFLAMMATION 7 0.0003
786 SWELLING 25 0.0003
787 CARDIAC ARREST 22 0.0003
788 NEPHROLITHIASIS 12 0.0003
789 CONSTIPATION 57 0.0003
790 HERPES ZOSTER 15 0.0003
791 POST PROCEDURAL COMPLICATION 5 0.0003
792 PSORIASIS 34 0.0003
793 NAUSEA 206 0.0003
794 DRUG PRESCRIBING ERROR 5 0.0003
795 DEVICE RELATED INFECTION 4 0.0003
796 MOOD ALTERED 7 0.0003
797 HAEMORRHOIDS 5 0.0003
798 BONE PAIN 15 0.0003
799 HYPERTENSION 54 0.0003
800 ARTHRITIS 20 0.0003
801 EPISTAXIS 19 0.0003
802 CHEST DISCOMFORT 26 0.0003
803 ANAPHYLACTIC REACTION 14 0.0003
804 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
805 WHEEZING 15 0.0003
806 HEAD INJURY 8 0.0003
807 DIVERTICULITIS 7 0.0003
808 PREMATURE DELIVERY 4 0.0003
809 OBESITY 4 0.0003
810 UPPER LIMB FRACTURE 5 0.0003
811 SENSORY DISTURBANCE 4 0.0002
812 MOVEMENT DISORDER 8 0.0002
813 PRODUCT PHYSICAL ISSUE 5 0.0002
814 C-REACTIVE PROTEIN INCREASED 9 0.0002
815 EXTRA DOSE ADMINISTERED 10 0.0002
816 TASTE DISORDER 5 0.0002
817 THROAT IRRITATION 11 0.0002
818 ADVERSE DRUG REACTION 22 0.0002
819 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
820 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
821 TOOTH LOSS 5 0.0002
822 LIVER FUNCTION TEST ABNORMAL 7 0.0002
823 VIRAL INFECTION 8 0.0002
824 SUICIDAL IDEATION 22 0.0002
825 DYSPNOEA EXERTIONAL 9 0.0002
826 ANXIETY 68 0.0002
827 INTESTINAL OBSTRUCTION 9 0.0002
828 THERAPY INTERRUPTED 17 0.0002
829 TREATMENT NONCOMPLIANCE 13 0.0002
830 MOBILITY DECREASED 17 0.0002
831 HEMIPARESIS 4 0.0002
832 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
833 HYPOPHAGIA 6 0.0002
834 HAEMOGLOBIN DECREASED 24 0.0002
835 IRRITABLE BOWEL SYNDROME 5 0.0002
836 UNDERDOSE 17 0.0002
837 SKIN CANCER 5 0.0002
838 PARANOIA 4 0.0002
839 RASH GENERALISED 6 0.0002
840 HAEMATOMA 6 0.0002
841 PLASMA CELL MYELOMA 9 0.0002
842 LOCAL SWELLING 4 0.0002
843 SEDATION 6 0.0002
844 PRODUCT SUBSTITUTION ISSUE 13 0.0002
845 MATERNAL EXPOSURE DURING PREGNANCY 20 0.0002
846 THIRST 4 0.0002
847 BONE DENSITY DECREASED 7 0.0002
848 FEAR 6 0.0002
849 GOUT 4 0.0002
850 NASAL CONGESTION 13 0.0002
851 NEUTROPHIL COUNT DECREASED 9 0.0002
852 BONE DISORDER 4 0.0002
853 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
854 CONTUSION 21 0.0002
855 FEELING ABNORMAL 52 0.0002
856 HYPOKALAEMIA 10 0.0002
857 MALAISE 95 0.0002
858 INJECTION SITE MASS 8 0.0002
859 FALL 72 0.0002
860 PERICARDIAL EFFUSION 5 0.0002
861 MEDICATION ERROR 12 0.0002
862 DYSGEUSIA 16 0.0002
863 DEPRESSION 49 0.0002
864 BLOOD CHOLESTEROL INCREASED 10 0.0002
865 ACCIDENTAL EXPOSURE TO PRODUCT 22 0.0002
866 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
867 PAIN IN EXTREMITY 62 0.0002
868 PROTEINURIA 4 0.0002
869 NEUROPATHY PERIPHERAL 20 0.0002
870 MUSCULOSKELETAL DISORDER 4 0.0002
871 RECTAL HAEMORRHAGE 9 0.0002
872 INCREASED APPETITE 4 0.0002
873 LOCALISED INFECTION 5 0.0002
874 MENTAL IMPAIRMENT 5 0.0002
875 FIBROMYALGIA 5 0.0002
876 NEURALGIA 5 0.0002
877 CHOKING 4 0.0002
878 PSYCHOTIC DISORDER 6 0.0002
879 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
880 HEART RATE DECREASED 7 0.0002
881 THROMBOSIS 16 0.0002
882 CORONARY ARTERY DISEASE 6 0.0002
883 PLEURAL EFFUSION 12 0.0002
884 DIABETES MELLITUS 15 0.0002
885 CEREBRAL HAEMORRHAGE 7 0.0002
886 LIMB DISCOMFORT 6 0.0002
887 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
888 RHABDOMYOLYSIS 8 0.0002
889 ABDOMINAL DISCOMFORT 32 0.0002
890 KNEE ARTHROPLASTY 4 0.0002
891 PULMONARY EMBOLISM 18 0.0002
892 PANCREATITIS 10 0.0002
893 BRONCHITIS 14 0.0002
894 OSTEOARTHRITIS 8 0.0002
895 MIGRAINE 18 0.0002
896 ABSCESS 3 0.0002
897 RETCHING 4 0.0002
898 HYPOACUSIS 8 0.0002
899 POOR QUALITY SLEEP 4 0.0002
900 INJECTION SITE ERYTHEMA 23 0.0002
901 CATARACT 11 0.0002
902 FOETAL EXPOSURE DURING PREGNANCY 15 0.0002
903 NASOPHARYNGITIS 34 0.0002
904 MEMORY IMPAIRMENT 25 0.0002
905 SUICIDE ATTEMPT 11 0.0002
906 ILL-DEFINED DISORDER 11 0.0002
907 FEBRILE NEUTROPENIA 12 0.0002
908 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
909 LEUKOPENIA 9 0.0002
910 INJECTION SITE PAIN 55 0.0002
911 WOUND 5 0.0002
912 GLOSSODYNIA 4 0.0002
913 PULMONARY OEDEMA 8 0.0002
914 HYPERHIDROSIS 23 0.0002
915 SNEEZING 4 0.0002
916 TYPE 2 DIABETES MELLITUS 6 0.0002
917 DISEASE PROGRESSION 21 0.0002
918 ANGER 6 0.0002
919 HEART RATE IRREGULAR 4 0.0002
920 GASTRIC DISORDER 6 0.0002
921 ABORTION SPONTANEOUS 7 0.0002
922 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
923 COGNITIVE DISORDER 8 0.0002
924 RENAL INJURY 5 0.0002
925 DRUG EFFECT DECREASED 9 0.0002
926 DIABETIC KETOACIDOSIS 4 0.0002
927 WEIGHT INCREASED 37 0.0002
928 INTERSTITIAL LUNG DISEASE 8 0.0002
929 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
930 STOMATITIS 10 0.0002
931 INJECTION SITE URTICARIA 4 0.0002
932 OSTEONECROSIS OF JAW 4 0.0002
933 AGEUSIA 4 0.0002
934 UNEVALUABLE EVENT 12 0.0002
935 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
936 INFLUENZA LIKE ILLNESS 13 0.0002
937 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
938 THERAPY CESSATION 8 0.0002
939 EXPOSURE VIA SKIN CONTACT 4 0.0002
940 DEEP VEIN THROMBOSIS 10 0.0002
941 INCORRECT DOSE ADMINISTERED 35 0.0002
942 DEATH 131 0.0002
943 INFUSION RELATED REACTION 10 0.0002
944 RENAL DISORDER 7 0.0002
945 DISTURBANCE IN ATTENTION 8 0.0001
946 MULTIPLE SCLEROSIS 7 0.0001
947 ABNORMAL DREAMS 4 0.0001
948 PROCEDURAL PAIN 4 0.0001
949 DRUG ABUSE 12 0.0001
950 INJECTION SITE SWELLING 11 0.0001
951 ROAD TRAFFIC ACCIDENT 6 0.0001
952 DEMENTIA 4 0.0001
953 CARDIAC DISORDER 13 0.0001
954 INJECTION SITE BRUISING 11 0.0001
955 DRUG EFFECT INCOMPLETE 5 0.0001
956 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
957 RESTLESSNESS 5 0.0001
958 DYSURIA 5 0.0001
959 ACUTE MYOCARDIAL INFARCTION 4 0.0001
960 LABORATORY TEST ABNORMAL 4 0.0001
961 NEOPLASM MALIGNANT 9 0.0001
962 INJECTION SITE PRURITUS 9 0.0001
963 COLITIS ULCERATIVE 6 0.0001
964 HAEMORRHAGE 14 0.0001
965 EPILEPSY 4 0.0001
966 INJECTION SITE RASH 4 0.0001
967 CEREBROVASCULAR ACCIDENT 21 0.0001
968 IMPAIRED HEALING 4 0.0001
969 POLLAKIURIA 5 0.0001
970 FLUID RETENTION 6 0.0001
971 NIGHTMARE 4 0.0001
972 INJURY 8 0.0001
973 PANIC ATTACK 4 0.0001
974 ARTHROPATHY 6 0.0001
975 PRODUCT DOSE OMISSION 7 0.0001
976 BLOOD GLUCOSE INCREASED 20 0.0001
977 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
978 DYSKINESIA 4 0.0001
979 RHEUMATOID ARTHRITIS 11 0.0001
980 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
981 NERVOUSNESS 5 0.0001
982 MUSCULOSKELETAL PAIN 5 0.0001
983 WITHDRAWAL SYNDROME 4 0.0001
984 PRODUCT STORAGE ERROR 8 0.0001
985 HOSPITALISATION 14 0.0001
986 INJECTION SITE REACTION 6 0.0001
987 DRUG DOSE OMISSION 14 0.0001
988 MYOCARDIAL INFARCTION 14 0.0001
989 CARDIAC FAILURE CONGESTIVE 6 0.0001
990 DEVICE MALFUNCTION 4 0.0001
991 INJECTION SITE HAEMORRHAGE 4 0.0001
992 PROSTATE CANCER 4 0.0000
993 DEVICE ISSUE 4 0.0000
994 DRUG DEPENDENCE 6 0.0000